-
公开(公告)号:JP2000109475A
公开(公告)日:2000-04-18
申请号:JP31294099
申请日:1999-11-02
Applicant: GLAXO INC
Inventor: LUZZIO MICHAEL J , BESTERMAN JEFFREY M , EVANS MICHAEL G , MYERS PETER LESLIE
IPC: A61K31/47 , A61K31/435 , A61K31/4738 , A61K31/4745 , A61K31/496 , A61K31/5377 , A61K31/541 , A61P35/00 , A61P43/00 , C07D317/66 , C07D319/18 , C07D491/22 , C07D498/22
Abstract: PROBLEM TO BE SOLVED: To obtain a new compound useful as an intermediate for producing a water-soluble camptothecin derivative used for treating tumors. SOLUTION: A compound of formula I [(n) is 1 or 2; R1, R2 are each H, a 1-6C alkyl or the like, or R1 is H, a 1-6C alkyl or the like and R2 is a group of the formula; COR3, or R1 and R2 are bonded to each other together with a nitrogen atom bonded thereto to form a saturated three to seven-membered heterogeneous group; R3 is H, a 1-6C alkyl or the like; Y is O, S or the like], for example, 2'-amino-4',5'-methylenedioxy-2-trifluoroacetamidoacetophenone. The compound of formula I is obtained by reacting a compound of formula III (X is a halogen) (for example, 2'-amino-4',5'-methylenedioxy-2- chloroacetophenone) with a compound of the formula: HNR1R2 (for example, trifluoroacetamine) in the presence of a base in an aprotic polar solvent such as acetonitrile.
-
公开(公告)号:JPH0625284A
公开(公告)日:1994-02-01
申请号:JP19321592
申请日:1992-06-26
Applicant: GLAXO INC
Inventor: MYERS PETER LESLIE , MCELROY ANDREW BRIAN , BROWN PETER JONATHAN , DREWRY DAVID HAROLD , FOLEY MICHAEL ANDREW , GREGSON MICHAEL , DAVIES HOWARD G
IPC: A61K38/55 , A61K38/00 , A61P1/02 , A61P17/00 , A61P19/10 , A61P25/02 , A61P29/00 , A61P35/00 , A61P43/00 , C07D209/48 , C07D209/66 , C07D471/04 , C07D471/14 , C07D487/04 , C07D487/14 , C07K1/06 , C07K1/113 , C07K5/02 , C07K5/06 , C07K5/08 , A61K37/64
-
公开(公告)号:CZ284023B6
公开(公告)日:1998-07-15
申请号:CS323792
申请日:1992-10-27
Applicant: GLAXO INC
Inventor: LUZZIO MICHAEL JOSEPH , BESTERMAN JEFFREY M , EVANS MICHAEL G , MYERS PETER LESLIE
IPC: A61K31/47 , A61K31/435 , A61K31/4738 , A61K31/4745 , A61K31/496 , A61K31/5377 , A61K31/541 , A61P35/00 , A61P43/00 , C07D317/66 , C07D319/18 , C07D491/22 , C07D498/22
Abstract: The invention relates to water soluble, camptothecin derivatives of formula (I), wherein: n represents the integer 1 or 2; and i) R and R represent independently, hydrogen, lower alkyl, (C PI 1/2 )cycloalkyl, (C PI 1/2 )cycloalkyl lower alkyl, lower alkenyl, hydroxy lower alkyl, lower alkoxy lower alkyl; ii) R represents hydrogen, lower alkyl, (C PI 1/2 )cycloalkyl, (C PI 1/2 )cycloalkyl lower alkyl, lower alkenyl, hydroxy lower alkyl or lower alkoxy lower alkyl, and R represents -COR wherein R represents hydrogen, lower alkyl, perhalo-lower alkyl, (C PI 1/2 )cycloalkyl, (C PI 1/2 )cycloalkyl lower alkyl, lower alkenyl, hydroxy lower alkyl, lower alkoxy, lower alkoxy lower alkyl; or iii) R and R taken together with the linking nitrogen form a saturated 3 to 7 atom heterocyclic group of formula (IA) wherein: Y represents O, S, CH , NR4 wherein R4 represents hydrogen, lower alkyl, perhalo-lower alkyl, aryl, aryl substituted with one or more lower alkyl, halogen, nitro, amino, lower alkyl amino, perhalo-lower alkyl, hydroxy lower alkyl, lower alkoxy, lower alkoxy lower alkyl groups or; -COR5 wherein R5 represents hydrogen, lower alkyl, perhalo-lower alkyl, lower alkoxy, aryl, aryl substituted with one or more lower alkyl, perhalo-lower alkyl, hydroxy lower alkyl, lower alkoxy lower alkyl groups; and the pharmaceutically acceptable salts thereof; their use in the treatment of tumors and methods of their preparation.
-
公开(公告)号:IS4152A
公开(公告)日:1994-10-30
申请号:IS4152
申请日:1994-04-25
Applicant: GLAXO INC
Inventor: LUZZIO MICHAEL JOSEPH , BESTERMAN JEFFREY MARK , EVANS MICHAEL G , MYERS PETER LESLIE
IPC: A61K20060101 , A61K31/47 , A61P35/00 , C07D20060101 , C07D317/66 , C07D319/18 , C07D491/22
-
公开(公告)号:NO924158L
公开(公告)日:1993-04-30
申请号:NO924158
申请日:1992-10-28
Applicant: GLAXO INC
Inventor: LUZZIO MICHAEL JOSEPH , BESTERMAN JEFFREY M , EVANS MICHAEL G , MYERS PETER LESLIE
IPC: A61K31/435 , A61K31/4738 , A61K31/47 , A61K31/4745 , A61K31/496 , A61K31/5377 , A61K31/541 , A61P35/00 , A61P43/00 , C07D317/66 , C07D319/18 , C07D491/22 , C07D498/22
Abstract: The invention relates to water soluble, camptothecin derivatives of formula (I), wherein: n represents the integer 1 or 2; and i) R and R represent independently, hydrogen, lower alkyl, (C PI 1/2 )cycloalkyl, (C PI 1/2 )cycloalkyl lower alkyl, lower alkenyl, hydroxy lower alkyl, lower alkoxy lower alkyl; ii) R represents hydrogen, lower alkyl, (C PI 1/2 )cycloalkyl, (C PI 1/2 )cycloalkyl lower alkyl, lower alkenyl, hydroxy lower alkyl or lower alkoxy lower alkyl, and R represents -COR wherein R represents hydrogen, lower alkyl, perhalo-lower alkyl, (C PI 1/2 )cycloalkyl, (C PI 1/2 )cycloalkyl lower alkyl, lower alkenyl, hydroxy lower alkyl, lower alkoxy, lower alkoxy lower alkyl; or iii) R and R taken together with the linking nitrogen form a saturated 3 to 7 atom heterocyclic group of formula (IA) wherein: Y represents O, S, CH , NR4 wherein R4 represents hydrogen, lower alkyl, perhalo-lower alkyl, aryl, aryl substituted with one or more lower alkyl, halogen, nitro, amino, lower alkyl amino, perhalo-lower alkyl, hydroxy lower alkyl, lower alkoxy, lower alkoxy lower alkyl groups or; -COR5 wherein R5 represents hydrogen, lower alkyl, perhalo-lower alkyl, lower alkoxy, aryl, aryl substituted with one or more lower alkyl, perhalo-lower alkyl, hydroxy lower alkyl, lower alkoxy lower alkyl groups; and the pharmaceutically acceptable salts thereof; their use in the treatment of tumors and methods of their preparation.
-
公开(公告)号:NO922530A
公开(公告)日:1992-12-28
申请号:NO922530
申请日:1992-06-26
Applicant: GLAXO INC
Inventor: MYERS PETER LESLIE , MCELROY ANDREW BRIAN , GREGSON MICHAEL , BROWN PETER JONATHAN , DAVIES HOWARD GEOFFREY , DREWRY DAVID HAROLD , FOLEY MICHAEL ANDREW
IPC: A61K38/55 , A61K38/00 , A61P1/02 , A61P17/00 , A61P19/10 , A61P25/02 , A61P29/00 , A61P35/00 , A61P43/00 , C07D209/48 , C07D209/66 , C07D471/04 , C07D471/14 , C07D487/04 , C07D487/14 , C07K1/06 , C07K1/113 , C07K5/02 , C07K5/06 , C07K5/08 , A61K37/64 , C07K5/10
CPC classification number: C07K5/0222 , A61K38/00
-
公开(公告)号:MY141374A
公开(公告)日:2010-04-16
申请号:MYPI9401039
申请日:1994-04-27
Applicant: GLAXO INC
Inventor: LUZZIO MICHAEL JOSEPH , BESTERMAN JEFFREY MARK , EVANS MICHAEL G , MYERS PETER LESLIE
IPC: C07D491/22 , A61K20060101 , A61K31/47 , A61P35/00 , C07D20060101 , C07D317/66 , C07D319/18
Abstract: THE PRESENT INVENTION RELATES TO WATER SOLUBLE, CAMPTOTHECIN DERIVATIVES OF FORMULA (I) WHEREIN N REPRESENTS THE INTEGER 1 OR 2; AND I) R1 REPRESENTS HYDROGEN, LOWER ALKYL, (C3-7)CYCLOALKYL, (C3-7)CYCLOALKYL LOWER ALKYL, LOWER ALKENYL, HYDROXY LOWER ALKYL, AMINO LOWER ALKYL, LOWER ALKYLAMINO LOWER ALKYL, AMINO LOWER ALKYL, LOWER ALKOXY LOWER ALKYL OR (CH2)TAR WHEREIN: T IS 0 TO 5 AND AR REPRESENTS PHENYL, FURYL, PYRIDYL, N-METHYLPYRROLYL, IMIDAZOLYL; OR PHENYL, FURYL, PYRIDYL, N-METHYLPYRROLYL, IMIDAZOLYL, WITH ONE OR MORE SUBSTITUENTS INDEPENDENTLY SELECTED FROM HYDROXY, METHOXY, HALOGEN AND AMINO; AND R2 REPRESENTS DIPHENYLMETHYL OR (CH2)TAR; OR II) R1 AND R2 TAKEN TOGETHER WITH THE LINKING NITROGEN REPRESENT N-TETRAHYDROQUINOLYL OR N-TETRAHYDROISOQUINOLYL; AND PHARMACEUTICALLY ACCEPTABLE SALTS AND SOLVATES THEREOF; THEIR USE AS TOPOISOMERASE INHIBITORS; THEIR PREPARATION; AND THEIR USE IN THE TREATMENT OF CANCER.
-
公开(公告)号:AP9400638A0
公开(公告)日:1995-10-28
申请号:AP9400638
申请日:1994-04-28
Applicant: GLAXO INC
IPC: A61K20060101 , A61K31/47 , A61P35/00 , C07D20060101 , C07D317/66 , C07D319/18 , C07D491/22
Abstract: The present invention relates to water soluble, camptothecin derivatives of formula (1)wherein n represents the integer 1 or 2; and r1 represents hydrogen, lower alkyl, (c3-7)cycloalkyl, (c3-7)cycloalkyl lower alkyl, lower alkenyl, hydroxy lower alkyl, amino lower alkyl, lower alkylamino lower alkyl, amino lower alkul, lower alkoxy lower alkyl or (ch2)tar wherein: t is 0 to 5 and ar represents phenyl, furyl, pyridyl, n-methylpyrrolyl, imidazolyl; or phenyl, furyl, pyridyl, n-methylpyrrolyl, imidazolyl, with one or more substituents independtly selected from hydroxy, methoxy, halogen and amino; and r2 represents diphenylmenthyl or (ch2)tar; or r1 and r2 taken together with the linking nitrogen represents n-tetrahydroquinolyl or n-tetrahydroisoquinolyl; and pharmaceutically acceptable salts and solvents thereof; their use as topoisomerase inhibitors; their preparations; and their use in the treatment of cancer.
-
公开(公告)号:PE52894A1
公开(公告)日:1995-01-06
申请号:PE24106194
申请日:1994-04-27
Applicant: GLAXO INC
IPC: A61K31/435 , A61K20060101 , A61K31/365 , A61K31/47 , A61P35/00 , C07D20060101 , C07D317/66 , C07D319/18 , C07D491/22
Abstract: SE REFIERE A UN COMPUESTO DE FORMULA I DONDE: 1) n VARIA DE 1 A 2; 2) R1 ES H, ALQUILO INFERIOR, CICLOALQUILO C3-C7, (CICLOALQUILO C3-C7)-ALQUILO INFERIOR, ALQUENILO INFERIOR, HIDROXIALQUILO INFERIOR, (CH2)t-Ar, DONDE t VARIA DE CERO A 5 Y Ar ES FENILO, FURILO, PIRIDILO, N-METILPIRROLILO, IMIDAZOLILO, SOLO O CON 1 o MAS SUSTITUYENTES COMO OH, OCH3, HALOGENO, AMINO; 3) R2 ES DIFENILMETILO, (CH2)t-Ar; o R1 Y R2 JUNTO CON EL ATOMO DE NITROGENO FORMAN N-TETRAHIDROQUINOLILO, N-TETRAHIDROISOQUINOLILO; EL CUAL A DIFERENCIA DE LA CAMPTOTECINA ES SOLUBLE EN AGUA Y PUEDE TENER ACTIVIDAD INHIBITORIA DE LA TOPOISOMERASA I - DNA IN VITRO Y ACTIVIDAD ANTITUMORAL IN VIVO
-
公开(公告)号:OA09767A
公开(公告)日:1993-11-30
申请号:OA60295
申请日:1992-10-28
Applicant: GLAXO INC
Inventor: LUZZIO MICHAEL JOSEPH , BESTERMAN JEFFREY M , EVANS MICHAEL G , MYERS PETER LESLIE
IPC: A61K31/435 , A61K31/47 , A61K31/4738 , A61K31/4745 , A61K31/496 , A61K31/5377 , A61K31/541 , A61P35/00 , A61P43/00 , C07D317/66 , C07D319/18 , C07D491/22 , C07D498/22
Abstract: The invention relates to water soluble, camptothecin derivatives of formula (I), wherein: n represents the integer 1 or 2; and i) R and R represent independently, hydrogen, lower alkyl, (C PI 1/2 )cycloalkyl, (C PI 1/2 )cycloalkyl lower alkyl, lower alkenyl, hydroxy lower alkyl, lower alkoxy lower alkyl; ii) R represents hydrogen, lower alkyl, (C PI 1/2 )cycloalkyl, (C PI 1/2 )cycloalkyl lower alkyl, lower alkenyl, hydroxy lower alkyl or lower alkoxy lower alkyl, and R represents -COR wherein R represents hydrogen, lower alkyl, perhalo-lower alkyl, (C PI 1/2 )cycloalkyl, (C PI 1/2 )cycloalkyl lower alkyl, lower alkenyl, hydroxy lower alkyl, lower alkoxy, lower alkoxy lower alkyl; or iii) R and R taken together with the linking nitrogen form a saturated 3 to 7 atom heterocyclic group of formula (IA) wherein: Y represents O, S, CH , NR4 wherein R4 represents hydrogen, lower alkyl, perhalo-lower alkyl, aryl, aryl substituted with one or more lower alkyl, halogen, nitro, amino, lower alkyl amino, perhalo-lower alkyl, hydroxy lower alkyl, lower alkoxy, lower alkoxy lower alkyl groups or; -COR5 wherein R5 represents hydrogen, lower alkyl, perhalo-lower alkyl, lower alkoxy, aryl, aryl substituted with one or more lower alkyl, perhalo-lower alkyl, hydroxy lower alkyl, lower alkoxy lower alkyl groups; and the pharmaceutically acceptable salts thereof; their use in the treatment of tumors and methods of their preparation.
-
-
-
-
-
-
-
-
-